Dennis Gillings

Fondateur chez GHO Capital Partners LLP

Profil

Dr. Dennis B. Gillings is a Chief Executive Officer at PharmaBio Development, Inc. and a Non-Executive Chair & Founder at GHO Capital Partners LLP.
He is on the Board of Directors at Neusentis, Inc. and Southampton University Development Trust.
Dr. Gillings was previously employed as a Pro-Chancellor by The University of Southampton, a Lead Director by IQVIA RDS, Inc., a Class I Director by Quintiles Transnational Holdings, Inc., a Founding Chairman by Association of Clinical Research Organizations, a Co-Founder by IQVIA Holdings, Inc., a Consultant by National Cancer Institute, and a Professor by The University of North Carolina at Charlotte.
He also served on the board at The Life Sciences Foundation, XRpro Sciences, Inc., North Carolina Institute of Medicine, Triangle Pharmaceuticals, Inc., UNC Health Care System and United Way of Greater Los Angeles.
He received his doctorate degree from The University of Exeter.

Postes actifs de Dennis Gillings

Sociétés	Poste	Début
Neusentis, Inc.	Directeur/Membre du Conseil	19/04/2011
Southampton University Development Trust	Directeur/Membre du Conseil	-
GHO Capital Partners LLP	Fondateur	01/01/2014
PharmaBio Development, Inc.	Directeur Général	01/01/2016

Anciens postes connus de Dennis Gillings

Sociétés	Poste	Fin
IQVIA RDS, Inc.	Fondateur	12/04/2018
Quintiles Transnational Holdings, Inc.	Directeur Général	01/10/2016
Icagen, Inc.	Directeur/Membre du Conseil	01/07/2011
The University of Southampton	Corporate Officer/Principal	01/01/2011
IQVIA HOLDINGS INC.	Fondateur	-